Since the first case reports in Wuhan, China, the SARS-CoV-2 has caused a pandemic and
took lives of> 8, 35,000 people globally. This single-stranded RNA virus uses Angiotensin …

Coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is currently the most concerning health problem …

Abstract The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 …

ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the
COVID-19 pandemic, it has become one of the most therapeutically targeted human …

Dear Editor, Since December 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused a pneumonia outbreak in Wuhan city, China, followed by global …

The ongoing outbreak of a new coronavirus (2019‐nCoV, or severe acute respiratory
syndrome coronavirus 2 [SARS‐CoV‐2]) has caused an epidemic of the acute respiratory …

Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with
hypertension, renin–angiotensin–aldosterone system pathway, and other cardiovascular …

Since the onset of the coronavirus pandemic in December 2019, the SARS-CoV-2 virus has
accounted for over 6.3 million lives resulting in the demand to develop novel therapeutic …

The COVID-19 pandemic is an emerging threat to global public health. While our current
understanding of COVID-19 pathogenesis is limited, a better understanding will help us …

Soluble angiotensin-converting enzyme 2 (sACE2) could be a therapeutic option to treat
coronavirus disease 2019 (COVID-19) infection. Severe acute respiratory syndrome …